Table 1.
Demographics of the study population
| Variable | Total cohort | Liver fibrosis stage | |||||
|---|---|---|---|---|---|---|---|
| F0 | F1 | F2 | F3 | F4 | |||
| Total number of patients | 252 | 134 | 8 | 10 | 18 | 82 | |
| Median age (interquartile range) | 59 (48–65) | 63 (50–74) | 64 (38–71) | 57 (43–64) | 48 (43–62) | 60 (54–65) | |
| Gender | Male | 140 (55.6%) | 68 (50.7%) | 3 (37.5%s) | 7 (70.0%) | 11 (61.1%) | 51 (62.2%) |
| Female | 112 (44.4%) | 66 (49.3%) | 5 (62.5%) | 3 (30.0%) | 7 (38.9%) | 31 (37.8%) | |
| Origin of histopathology specimen | Biopsy | 39 (33.1%) | - | 7 | 6 | 6 | 17 |
| Resection | 5 (4.2%) | - | 0 | 0 | 0 | 5 | |
| Transplantation | 74 (62.7%) | - | 1 | 4 | 12 | 57 | |
| Etiology of liver fibrosis | Alcoholic | 26 (22.0%) | - | 0 | 0 | 1 | 25 |
| Autoimmune hepatitis | 5 (4.2%) | - | 0 | 1 | 1 | 3 | |
| HBV | 3 (2.5%) | - | 0 | 0 | 0 | 3 | |
| HCV | 10 (8.5%) | - | 0 | 0 | 1 | 9 | |
| PSC | 3 (2.5%) | - | 0 | 2 | 1 | 0 | |
| Steatohepatitis | 8 (6.8%) | - | 0 | 0 | 0 | 8 | |
| Wilson disease | 1 (0.8%) | - | 0 | 0 | 0 | 1 | |
| Other | 17 (14.4%) | - | 1 | 0 | 7 | 9 | |
| Unknown | 45 (38.1) | - | 7 | 7 | 7 | 24 | |
Abbreviations: HBV = hepatitis B virus; HCV = hepatitis C virus; PSC = primary sclerosing cholangitis